EFA eNews
In this section you will find:
- This month's EFA ezine
- An archive of past ezines
- Press information: releases, backgrounders etc.
- News from the...
Our Activities
For the past 20 years EFA has advocated the inclusion of patient perspective in EU projects and published fliers and documents to promote awareness of...
About EFA
Patients and their needs and rights are at the heart of everything we do. The European Federation of Allergy and Airways Diseases Patients Associations...
Contact
[contact-form-7 id="1724" title="Contact form 1"]
INTRALYMPHATIC IMMUNOTHERAPY
Background: Subcutaneous allergen-specific immunotherapy frequently causes allergic side effects and requires 30 to 80 injections over 3 to 5 years.
Objective: We...
EFA Members “Meet and Greet” EU Institutions Training
Starting in 2007, the EFA Secretariat has organised an event in Brussels called the “EFA Members ‘Meet and Greet’ EU Institutions Training,” which...
EFA at the Forum on active and healthy ageing
In the framework of the European Year for Active Ageing and Solidarity between Generations, the Committee of Regions organised a forum to provide local...
EFA at the launch of the European COPD Coalition
Susanna Palkonen together with some EFA members took part in the launch event of the ECC at the European Parliament, hosted by MEP Glenis Wilmott. The...
Patient group involvement during EAACI Annual Conference
The EAACI (European Academy of Allergy and Clinical Immunology) annual conference is to be held this year from June 16th to 20th in Geneva, under the official...
EU adopts new health warnings for tobacco packaging
On March 7, the European Commission adopted a Directive introducing a set of 14 new written health warnings due to appear on tobacco packaging in the near...
Mid-term evaluation of EU Health Programme
The EU Health Programme is one of the EU’s main instruments for improving European public health. It proposes various funding schemes for European health...
Open dialogue between EU institutions and citizens
The EU Health Programme is one of the EU’s main instruments for improving European public health. It proposes various funding schemes for European health...
EFA at Innovative Medicines Initiative (IMI) Open Info Day
On February 27th, David Brennan represented EFA at the IMI Open Info Day for its 5th Call for proposals in order to learn about the revised scientific...
Implementation of the EU Pharmacovigilance legislation
On February 27th, David Brennan represented EFA at the IMI Open Info Day for its 5th Call for proposals in order to learn about the revised scientific...
EFA attends EAACI workshop at the European Parliament
On the 21st of March, the European Academy of Allergy and Clinical Immunology (EAACI) organised a public workshop at the European Parliament on allergies...
EFA “Meet and Greet the EU Institutions” Training
On the 20th and 21st of March, EFA organised our third “Meet and Greet the EU Institutions” training for members. Thanks to this event, EFA members...
Latest EU health policy developments
March 2012 Issue
EU News: Latest EU health policy developments
The last months of 2011 and the beginning of 2012 have been particularly fruitful in...
ENSP General Assembly
The General Assembly (GA) of ENSP took place in Brussels on the 29th of February. EFA was represented by its EU Policy and Project Officer, Roberta Savli....
EU citizens' participation in the EU decision making process
The Austrian Institute for European Law and Policy, in cooperation with the Centre for European Policy Studies (CEPS) and Danube University, has been organising...
New food labelling regulation
After almost three years of negotiations, the European Parliament and the Council of the European Union adopted the final text of the new Regulation on...